Smith, Catrin Tudur

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., Cramp, C., Cockerell, O. C., Cooper, P. N., Doughty, J., et al. (2007) · The Lancet

Epilepsy research and treatmentPharmacological Effects and Toxicity Studies

Cited by 976

Interventions to improve recruitment and retention in clinical trials: a survey and workshop to assess current practice and future priorities

Bower, P., Brueton, V., Gamble, C., Treweek, S., Smith, C. T., Young, B., & Williamson, P. (2014) · Trials

Ethics in Clinical ResearchStatistical Methods in Clinical Trials

Cited by 369

Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial

Bonnett, L., Smith, C. T., Smith, D., Williamson, P., Chadwick, D., & Marson, A. G. (2012) · The Lancet Neurology

Epilepsy research and treatmentPharmacological Effects and Toxicity Studies

Cited by 69